Remove Barriers

To Ensure Launch Success and Accelerate Uptake

  • Clinical Trial Design to Maximize Market Access
  • Pricing Strategies
  • Coding Applications
  • Patient Assistance Planning
  • Coverage Advocacy With Payers
  • Prior to FDA approval and post-launch
  • Representing clients to Medicare and Medicaid, all private insurers, and ICER
  • Since 1998, Pricing and Market Access Support for Hundreds of Drugs and Devices
  • Specializing in drugs that are high cost, clinically complex, combinations with devices/diagnostics, Orphan or 505(b)(2)
  • Focusing on adoption and revision of government and private insurance coverage policies for those products